Annual Working Capital
$1.62 B
+$2.25 B+357.32%
March 31, 2024
Summary
- As of February 25, 2025, TAK annual working capital is $1.62 billion, with the most recent change of +$2.25 billion (+357.32%) on March 31, 2024.
- During the last 3 years, TAK annual working capital has fallen by -$6.90 billion (-80.96%).
- TAK annual working capital is now -91.07% below its all-time high of $18.17 billion, reached on March 31, 2008.
Performance
TAK Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$4.18 B
-$489.30 M-10.48%
December 1, 2024
Summary
- As of February 25, 2025, TAK quarterly working capital is $4.18 billion, with the most recent change of -$489.30 million (-10.48%) on December 1, 2024.
- Over the past year, TAK quarterly working capital has stayed the same.
- TAK quarterly working capital is now -74.35% below its all-time high of $16.30 billion, reached on December 31, 2018.
Performance
TAK Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TAK Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +357.3% | 0.0% |
| 3 y3 years | -81.0% | 0.0% |
| 5 y5 years | -59.1% | 0.0% |
TAK Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.0% | +357.3% | -28.1% | +763.1% |
| 5 y | 5-year | -81.0% | +357.3% | -50.9% | +763.1% |
| alltime | all time | -91.1% | +271.2% | -74.3% | +541.1% |
Takeda Pharmaceutical Company Limited Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $4.18 B(-10.5%) |
| Sep 2024 | - | $4.67 B(+17.0%) |
| Jun 2024 | - | $3.99 B(+146.1%) |
| Mar 2024 | $1.62 B(-357.3%) | $1.62 B(+56.0%) |
| Dec 2023 | - | $1.04 B(+64.5%) |
| Sep 2023 | - | $632.24 M(-408.0%) |
| Jun 2023 | - | -$205.27 M(-67.4%) |
| Mar 2023 | -$630.30 M(-117.2%) | -$630.30 M(-123.0%) |
| Dec 2022 | - | $2.74 B(+11.8%) |
| Sep 2022 | - | $2.45 B(-12.5%) |
| Jun 2022 | - | $2.80 B(-23.7%) |
| Mar 2022 | $3.67 B(-56.9%) | $3.67 B(-36.8%) |
| Dec 2021 | - | $5.81 B(+21.0%) |
| Sep 2021 | - | $4.80 B(-31.0%) |
| Jun 2021 | - | $6.96 B(-18.3%) |
| Mar 2021 | $8.52 B(+213.6%) | $8.52 B(+8.2%) |
| Dec 2020 | - | $7.87 B(-5.0%) |
| Sep 2020 | - | $8.28 B(+101.1%) |
| Jun 2020 | - | $4.12 B(+51.7%) |
| Mar 2020 | $2.72 B(-31.6%) | $2.72 B(-24.7%) |
| Dec 2019 | - | $3.61 B(-47.3%) |
| Sep 2019 | - | $6.85 B(-20.1%) |
| Jun 2019 | - | $8.58 B(+116.2%) |
| Mar 2019 | $3.97 B(+23.6%) | $3.97 B(-75.7%) |
| Dec 2018 | - | $16.30 B(+602.5%) |
| Sep 2018 | - | $2.32 B(-17.3%) |
| Jun 2018 | - | $2.81 B(-12.6%) |
| Mar 2018 | $3.21 B(-439.0%) | $3.21 B(-6.6%) |
| Dec 2017 | - | $3.44 B(+1.0%) |
| Sep 2017 | - | $3.41 B(+15.2%) |
| Jun 2017 | - | $2.96 B(-412.0%) |
| Mar 2017 | -$947.44 M(-120.6%) | -$947.44 M(-115.8%) |
| Dec 2016 | - | $6.00 B(-10.0%) |
| Sep 2016 | - | $6.67 B(+5.4%) |
| Jun 2016 | - | $6.33 B(+37.7%) |
| Mar 2016 | $4.60 B | $4.60 B(+2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $4.47 B(+8.4%) |
| Sep 2015 | - | $4.12 B(+9.8%) |
| Jun 2015 | - | $3.75 B(-10.5%) |
| Mar 2015 | $4.19 B(-45.4%) | $4.19 B(-42.2%) |
| Dec 2014 | - | $7.25 B(-7.2%) |
| Sep 2014 | - | $7.81 B(+0.2%) |
| Jun 2014 | - | $7.80 B(+1.6%) |
| Mar 2014 | $7.67 B(+20.9%) | $7.67 B(-33.1%) |
| Dec 2013 | - | $11.47 B(-3.8%) |
| Sep 2013 | - | $11.92 B(+39.9%) |
| Jun 2013 | - | $8.52 B(+34.2%) |
| Mar 2013 | $6.35 B(+72.7%) | $6.35 B(-28.1%) |
| Dec 2012 | - | $8.82 B(-9.1%) |
| Sep 2012 | - | $9.70 B(+63.6%) |
| Jun 2012 | - | $5.93 B(+61.4%) |
| Mar 2012 | $3.68 B(-73.4%) | $3.68 B(+33.5%) |
| Dec 2011 | - | $2.75 B(-17.9%) |
| Sep 2011 | - | $3.35 B(-76.6%) |
| Jun 2011 | - | $14.30 B(+3.5%) |
| Mar 2011 | $13.82 B(+13.0%) | $13.82 B(+1.7%) |
| Dec 2010 | - | $13.59 B(+1.2%) |
| Sep 2010 | - | $13.43 B(+8.2%) |
| Jun 2010 | - | $12.41 B(+1.4%) |
| Mar 2010 | $12.23 B(+20.7%) | $12.23 B(+6.3%) |
| Dec 2009 | - | $11.51 B(-3.8%) |
| Sep 2009 | - | $11.97 B(+18.1%) |
| Mar 2009 | $10.14 B(-44.2%) | $10.14 B(+2.4%) |
| Dec 2008 | - | $9.89 B |
| Mar 2008 | $18.17 B(+11.9%) | - |
| Mar 2007 | $16.24 B(+1.6%) | - |
| Mar 2006 | $15.99 B(+6.8%) | - |
| Mar 2005 | $14.97 B(+14.7%) | - |
| Mar 2004 | $13.05 B(+28.6%) | - |
| Mar 2003 | $10.15 B(+38.6%) | - |
| Mar 2002 | $7.32 B(+16.4%) | - |
| Mar 2001 | $6.29 B | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual working capital?
- What is the all time high annual working capital for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual working capital year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly working capital?
- What is the all time high quarterly working capital for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly working capital year-on-year change?
What is Takeda Pharmaceutical Company Limited annual working capital?
The current annual working capital of TAK is $1.62 B
What is the all time high annual working capital for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual working capital is $18.17 B
What is Takeda Pharmaceutical Company Limited annual working capital year-on-year change?
Over the past year, TAK annual working capital has changed by +$2.25 B (+357.32%)
What is Takeda Pharmaceutical Company Limited quarterly working capital?
The current quarterly working capital of TAK is $4.18 B
What is the all time high quarterly working capital for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly working capital is $16.30 B
What is Takeda Pharmaceutical Company Limited quarterly working capital year-on-year change?
Over the past year, TAK quarterly working capital has changed by $0.00 (0.00%)